180 LIFE SCIENCES CORP (ATNF) Stock Income Statement
NASDAQ:ATNF - Nasdaq - US68236V3024 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 6.61M | 6.32M | 13.48M | 17.90M | 15.64M | |||
| Research and Development | 1.81M | 1.97M | 2.78M | 2.43M | 3.95M | |||
| Selling, General, and Administrative Expenses | 4.80M | 4.30M | 10.59M | 15.36M | 11.58M | |||
| Operating Income | -6.61M | -6.32M | -13.48M | -17.90M | -15.64M | |||
| Interest Income/Expense | 155.50K | 141.50K | 30.50K | 15.12M | -4.86M | |||
| Other Income/Expense | 212.60K | 1.25M | 21.10K | 0.00 | 166.50K | |||
| Non Recurring Items | N/A | -1.53M | -8.86M | -36.89M | -9.70K | |||
| Income Before Taxes | -7.76M | -6.46M | -22.28M | -39.67M | -20.35M | |||
| Income Tax | N/A | -296.00K | -2.35M | -942.70K | -23.20K | |||
| Net Income | -15.48M | -14.18M | -19.94M | -38.73M | -20.32M | |||
| EBITDA | N/A | -6.27M | -13.37M | -17.79M | -15.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -12.46 | -15.49 | -52.59 | -387.26 | -246.36 | |||
| Statistics | ||||||||
All data in USD